Pregnancy and contraception in sickle cell disease;Gravidez e contracepção na doença falciforme

Revista Brasileira de Hematologia e Hemoterapia

Volumn 29, Issue 3, 2007, Pages 309-312

  Zanette, Angela Maria D ^a,b  

^a Fundação de Hematologia e Hemoterapia da Bahia Hemoba

^b Fundacao de Hematologia e Hemoterapia do Estado da Bahia HEMOBA   (Brazil)

Author keywords

Hemoglobinopathies; Hemoglobinopathy SC; Sickle cell anemia

Indexed keywords

EID: 38049166288     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Lukens JN. Hemoglobinopathies S,C,D,E and O and associated diseases. In: Lee RG, Bithell TC, Foerster J, Athens JW, Lukens JN. Wintrobe's Clinical Hematology. Philadelphia:Lea & Febiger; 1993.p. 1061-1101.
2. WHO. Medical eligibility criteria for contraceptive use. Third Edition, 2004. Reproductive Health and Research, World Health Organization, Geneva.
3. Frye CA. An overview of oral contraceptives. Mechanism of action and clinical use. Neurology. 2006;66:Sa29-S36.
4. Yoong WC, Tuck SM, Pasi KJ, Owens D, Perry DJ. Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: effects of differing forms of hormonal contraception. Eur J Haematol. 2003;70:310-4.
5. Yoong WC, Tuck SM, Yardumian A. Red cell deformability in oral contraceptive pill users with sickle cell anaemia. Br J Haematol. 1999;104:868-70.
6. Yoong WC, Tuck SM, Michael AE. Binding of ovarian steroids to erythrocyte in patients with sickle cell disease;effects on cell sickling and osmotic fragility. Journal of Steroid Biochemistry & Molecular Biology. 2003;84:71-78.
7. ACOG Practice Bulletin no 73. Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107(6):1453-72.
8. De Ceulaer K, Gruber C, Hayes R, Serjeant GR. Medroxyprogesterone acetate and homozygous sickle cell disease. Lancet. 1982; 2: 229-31.
9. Leborgne-Samuel Y, Janky E, Venditelli F et al. Drépanocytose et grossesse:revue de 68 observations en Guadeloupe. J Gynecol Obstet Biol Reprod 2000;29:86-93.
10. Serjeant GR, Loy LL, Crowther MB, Hambleton IR, Thame M. Outcome of pregnancy in homozygous sickle cell disease. Obstet Gynecol. 2004;103:1278-85.
11. Serjeant GR, Hambleton I, Thame M. Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth. British Journal of Obstetrics and Gynaecology. 2005;112:1308-14.
12. Trampont P, Roudier M, Andrea AM et al. The placental-umbilical unit in sickle cell disease pregnancy: a model for studying in vivo functional adjustments for hypoxia in humans. Human Pathology. 2004;35(11):1353-9.
13. Rappaport VJ, Velazquez M, Williams K. Hemoglobinopathies in pregnancy. Obstet Gynaecol Clin N Am. 2004;31:287-317.
14. Sun PB, Wilburn W, Raynor BD et al. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol. 2001;184:1127-30.
15. Koshy M, Burd L. Management of pregnancy in sickle cell syndromes. Hematology/Oncology Clinics of North America. 1991;5(3):585-96.
16. Dauphin-McKenzie N, Gilles JM, Jacques E, Harrington T. Sickle cell anemia in the female patient. Obstetrical and Gynecological Survey. 2006;61(5):343-52.
17. ACOG Practice Bulletin. Hemoglobinopathies in Pregnancy. Obstetrics & Gynecology. 2005;106(1):203-11.
18. Roberts I. The role of hydroxyurea in sickle cell disease. Br J Haematol. 2003;120:177-86.